Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Discovery of Small Molecules That Target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP3)-Dependent Rac Exchanger 1 (P-Rex1) PIP3-Binding Site and Inhibit P-Rex1–Dependent Functions in Neutrophils

Jennifer N. Cash, Naincy R. Chandan, Alan Y. Hsu, Prateek V. Sharma, Qing Deng, Alan V. Smrcka and John J.G. Tesmer
Molecular Pharmacology March 2020, 97 (3) 226-236; DOI: https://doi.org/10.1124/mol.119.117556
Jennifer N. Cash
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer N. Cash
Naincy R. Chandan
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Y. Hsu
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alan Y. Hsu
Prateek V. Sharma
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Deng
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qing Deng
Alan V. Smrcka
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J.G. Tesmer
Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (J.N.C., P.V.S.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (N.R.C., A.V.S.); and Departments of Biological Sciences (A.Y.H., Q.D., J.J.G.T.) and Medicinal Chemistry and Molecular Pharmacology (J.J.G.T.), Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John J.G. Tesmer
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Phosphatidylinositol (3,4,5) trisphosphate (PIP3)-dependent Rac exchanger 1 (P-Rex1) is a Rho guanine-nucleotide exchange factor that was originally discovered in neutrophils and is regulated by G protein βγ subunits and the lipid PIP3 in response to chemoattractants. P-Rex1 has also become increasingly recognized for its role in promoting metastasis of breast cancer, prostate cancer, and melanoma. Recent structural, biochemical, and biologic work has shown that binding of PIP3 to the pleckstrin homology (PH) domain of P-Rex1 is required for its activation in cells. Here, differential scanning fluorimetry was used in a medium-throughput screen to identify six small molecules that interact with the P-Rex1 PH domain and block binding of and activation by PIP3. Three of these compounds inhibit N-formylmethionyl-leucyl-phenylalanine induced spreading of human neutrophils as well as activation of the GTPase Rac2, both of which are downstream effects of P-Rex1 activity. Furthermore, one of these compounds reduces neutrophil velocity and inhibits neutrophil recruitment in response to inflammation in a zebrafish model. These results suggest that the PH domain of P-Rex1 is a tractable drug target and that these compounds might be useful for inhibiting P-Rex1 in other experimental contexts.

SIGNIFICANCE STATEMENT A set of small molecules identified in a thermal shift screen directed against the phosphatidylinositol (3,4,5) trisphosphate–dependent Rac exchanger 1 (P-Rex1) pleckstrin homology domain has effects consistent with P-Rex1 inhibition in neutrophils.

Footnotes

    • Received June 11, 2019.
    • Accepted December 19, 2019.
  • This work was supported by the National Institutes of Health (NIH) National Cancer Institute and National Heart, Lung, and Blood Institute [Grants R01CA221289, R01HL122416, R01HL071818], a University of Michigan Center for the Discovery of New Medicines FY15 Round 1 grant, and the Walther Cancer Foundation (J.J.G.T.), the NIH National Institue of General Medical Sciences [Grant R35GM127303] (A.V.S.), a Michigan Pharmacology Centennial Fund Predoctoral Fellowship and a Benedict and Diana Lucchesi Fellowship (N.R.C.), the NIH National Institue of General Medical Sciences [Grant R35GM119787] (Q.D.), and a Purdue Cagiantas fellowship (A.Y.H). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The authors would also like to acknowledge the contribution of American Cancer Society – Michigan Cancer Research Fund Postdoctoral Fellowship PF-14-224-01-DMC (J.N.C).

  • https://doi.org/10.1124/mol.119.117556.

  • ↵Embedded ImageThis article has supplemental material available at molpharm.aspetjournals.org.

  • Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 97 (3)
Molecular Pharmacology
Vol. 97, Issue 3
1 Mar 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Discovery of Small Molecules That Target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP3)-Dependent Rac Exchanger 1 (P-Rex1) PIP3-Binding Site and Inhibit P-Rex1–Dependent Functions in Neutrophils
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Compounds Targeting the P-Rex1 PH Domain

Jennifer N. Cash, Naincy R. Chandan, Alan Y. Hsu, Prateek V. Sharma, Qing Deng, Alan V. Smrcka and John J.G. Tesmer
Molecular Pharmacology March 1, 2020, 97 (3) 226-236; DOI: https://doi.org/10.1124/mol.119.117556

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Compounds Targeting the P-Rex1 PH Domain

Jennifer N. Cash, Naincy R. Chandan, Alan Y. Hsu, Prateek V. Sharma, Qing Deng, Alan V. Smrcka and John J.G. Tesmer
Molecular Pharmacology March 1, 2020, 97 (3) 226-236; DOI: https://doi.org/10.1124/mol.119.117556
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics